STOCKWATCH
·
Pharmaceuticals
Quarterly Result14 Nov 2025, 08:49 am

Natural Capsules Ltd Reports Q2 & H1FY26 Results: Revenue at ₹ 91.01 Cr, EBITDA Margin at 13.18%

AI Summary

Natural Capsules Limited, a leading manufacturer of hard capsules shell, has announced its financial results for the quarter ended September 30, 2025. The company reported a revenue of ₹ 91.01 Cr for the half year ended September 30, 2025, with EBITDA margins at 13.18%. The Q2 has been stable, but the growth triggers were affected due to tariffs imposed on Indian exports to the US. The company is facing technical difficulties in scaling up fermentation batches for its API plant.

Key Highlights

  • Revenue for H1FY26 is ₹ 91.01 Cr
  • EBITDA Margin for H1FY26 is 13.18%
  • Q2FY26 has been a stable quarter for the capsules business
  • US tariffs affected the growth from HPMC expansion
  • Technical difficulties are causing delays in API plant scale-up
NATCAPSUQ
Pharmaceuticals
NATURAL CAPSULES LTD.

Price Impact